Mass Spectrometry in Single Bladder Cancer Cells

Completed

Conditions studied: Bladder Cancer

In brief

The study is a pilot study in the feasibility of a diagnostic technique. There is no current data on detection of cisplatin in cancer cells derived from human urine. This study will generate preliminary data so that future studies may be done with more definitive end points in mind.

Key facts

Study ID

NCT03639090

Run by

University of Oklahoma

People needed

2

Starts

2017-07-01

Expected to finish

2020-10-08

Last updated by the study team

2020-10-19

Who can join

Age: 30 and older, up to 99. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Patients must have a diagnosis of bladder cancer
• Patients must be undergoing their first cycle of cisplatin based chemotherapy due to metastatic disease or as pre-operative treatment before cystectomy
• Patients with a diagnosis of bladder cancer who will not be undergoing chemotherapy
• Patients must have demonstrated positive urinary cytology prior to inclusion in the study

You may not qualify if…

• Patients who do not have bladder cancer.

Where it is running

• University of Oklahoma HSC, Department of Urology — Oklahoma City, Oklahoma, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.